We are honored to receive this recognition in the category “Diagnostic Support and Performance” at this year’s
This award highlights our commitment to advancing precision oncology through cutting-edge diagnostic innovation. Our work in identifying microsatellite instability (MSI) in solid tumors is helping clinicians personalize cancer treatment with greater confidence and impact.
🎤 Our CEO, Arnaud Cutivet, proudly accepted the award on behalf of the team!
🙏 A huge thank you to **Fonds FHF Recherche & Innovation** and **Roche Diagnostics France** for supporting innovation in healthcare.
👏 Congratulations to the other outstanding nominees in our category:
- **Dalia** for their work in psychiatry
- **Virtuosis AI** for innovation in vocal biomarkers
… and to all the honorees who are shaping the future of healthcare.
We’re proud to be part of a thriving ecosystem alongside innovators like: Medtronic, Intuitive, Microsoft, **Advanced Accelerator Applications** – a **Novartis** Company, and the entire **SantExpo** community.
Here’s to pushing diagnostics further, together. 💡🔬
